Updates

Treatt - 95% gain since our main write up in November â€˜16

February 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Since our last update, Treatt has raised £21.6m by placing 5.3m shares at 410p to accelerate its US expansion plans and relocate its UK plant. The placing at 410p is almost twice the 217.5p price at which we made the shares a main buy in November 2016. Very nice.The placing was announced at the same time as its full year results. These showed adjusted profit before tax climbed 46% to £12.9m on sales up 24.5% to £109.6m. Eps climbed 42% to 18.3p.Treatt operates in the natural flavourings market, which is worth an estimated US$40bn. What has been galvanising the business recently is the emphasis on the beverages space as opposed to food - in particular beverages are more dynamic with regular innovation. The ot ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

First Derivatives

EMIS

Treatt (May 2023)

Treatt (September 2022)

Treatt - Explosive growth trajectory; gain 336% (March 2021)

Treatt - To exceed even recently upgraded forecasts (May 2017)

Treatt - Trading substantially ahead of forecasts (March 2017)

Treatt - Sugar free flavourings take off (November 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X